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Abstract
Background: In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in France.
Virological surveillance was undertaken in reference laboratories of the seven French Defence Zones.
Methodology/Principal Findings: We report results of virological analyses performed in the Public Hospitals of Marseille
during the first months of the outbreak. (i) Nasal swabs were tested using rapid influenza diagnostic test (RIDT) and two RT-
PCR assays. Epidemiological characteristics of the 99 first suspected cases were analyzed, including detection of influenza
virus and 18 other respiratory viruses. During three months, a total of 1,815 patients were tested (including 236 patients
infected H1N1sw virus) and distribution in age groups and results of RIDT were analyzed. (ii) 600 sera received before April
2009 and randomly selected from in-patients were tested by a standard hemagglutination inhibition assay for antibody to
the novel H1N1sw virus. (iii) One early (May 2009) and one late (July 2009) viral isolates were characterized by sequencing
the complete hemagglutinine and neuraminidase genes. (iiii) Epidemiological characteristics of a cluster of cases that
occurred in July 2009 in a summer camp were analyzed.
Conclusions/Significance: This study presents new virological and epidemiological data regarding infection by the
pandemic A/H1N1 virus in Europe. Distribution in age groups was found to be similar to that previously reported for
seasonal H1N1. The first seroprevalence data made available for a European population suggest a previous exposure of
individuals over 40 years old to influenza viruses antigenically related to the pandemic (H1N1)-2009 virus. Genomic analysis
indicates that strains harbouring a new amino-acid pattern in the neuraminidase gene appeared secondarily and tended to
supplant the first strains. Finally, in contrast with previous reports, our data support the use of RIDT for the detection of
infection in children, especially in the context of the investigation of grouped cases.
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Introduction
The first cases of the new H1N1 pandemic influenza virus
(H1N1sw), in metropolitan France, were detected in April 2009 in
patients returning from Mexico. Systematic analysis of suspected
cases [1] was undertaken and the virus was identified, using
molecular methods, in the Public Hospital virology ‘‘Level A’’
laboratories of the seven French Defence Zones. Accordingly,
samples from the Southern Defence Zone (a large geographical
region encompassing Corsica and the Mediterranean costal zone
from the Spanish border to the Italian border with approximately
8 million inhabitants), were received and analysed in our
department, at the Virology Level A laboratory of the Public
Hospitals of Marseille.
The current study refers to samples received between the end of
April and the end of August 2009. During the first period (until
mid-July), samples were systematically collected using strict and
identical criteria, mainly based either on the presence of an acute
respiratory illness and recent travel history in an affected area, or
on contact with a confirmed or suspected case. During the second
period, biological confirmation of suspected cases was no longer
required and criteria used for requesting biological diagnosis
(grouped cases, severe or atypical presentations, pre-existing
condition etc.) were more heterogeneous.
Here, we present the results of virological analyses performed
during the first three months that followed the introduction of the
novel H1N1sw pandemic influenza variant in metropolitan
France. This included the detection and characterization of
influenza viruses, the evaluation of rapid Influenza detection tests
(RIDTs) detection of the H1N1sw pandemic variant, the detection
of other respiratory viruses and the investigation of grouped cases.
In addition, the distribution of specific antibody to the new virus
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9214was investigated according to age groups in a sample of 600
individuals. Altogether, these data shed new light on the
determinants of the epidemiological distribution of viral infection
in the French population.
Methods
Samples Collected between April 25
th, 2009 and August
31
st, 2009
The biological material studied here was used only for standard
diagnostic procedures following physicians’ prescriptions (no
specific sampling, no modification of the sampling protocol).
Analysis of data was performed using an anonymized database.
Following local regulations, this procedure did not require a
specific consent from patients.
Nasal swabs received between April 25
th, 2009 and August 31
st,
2009 were included in the study (see figure 1). Until mid-July 2009,
criteria used for sample collection were strict and identical for all
patients: a possible case was defined as a person with acute
respiratory illness (defined as the occurrence of fever (.38uC) or
myalgia or asthenia and at least one respiratory symptom (cough
or dyspnoea) and a history of travel in an affected area or a history
of close contact with a confirmed or possible case one day to seven
days before the onset of symptoms. In order to capture cases from
previously undetected chains of transmission, clusters of acute
respiratory illness defined as at least three cases in a week in closed
communities were also to be notified [1]. During the subsequent
period, criteria used for requesting biological diagnosis were
modified. The biological confirmation of suspected cases was no
longer systematic, an increasing number of patients with influenza-
like presentation and no history of travel abroad or contact with
documented cases was tested, including grouped cases, severe or
atypical presentations, patients with pre-existing condition etc. In
addition, a Point Of Care (POC) strategy was applied from June
23
rd for the Public Hospitals of Marseilles [2] (see figure 1).
Accordingly, three different panels were studied: (i) The first 99
samples collected until June 15
th, 2009 using the systematic criteria
for suspected cases reported above in the Southern Defence Zone
(Panel A).(ii) All 280 samples collected from April 25
th, 2009 to
July 13
th, 2009 using the systematic criteria for suspected cases
reported above in the Southern Defence Zone (Panel B). (iii) The
total of all 1,815 samples collected by our group during the study
period (Panel C, see figure 1).
All samples were tested for the presence of Influenza A virus
using a pan-influenza A real time PCR technique as described
elsewhere [3] and a second real time PCR specific for the new
H1N1 variant [1]. In addition, the first 99 samples collected (Panel
A) were also tested by real time PCR techniques for the presence
of a panel of 18 different respiratory viral pathogens
[3,4,5,6,7,8,9,10,11,12,13,14,15,16] (see table 1).
Viral Loads, RIDTs
During the period of study, 1808 samples received in our
department were tested using the Directigen ‘‘BD EZ A+B’’
(Becton Dickinson & company) RIDT for the detection of
influenza A and B antigens.
TheH1N1swviralload wasinvestigatedin41positivesamples by
re-extracting samples and amplifying them simultaneously using a
probe-based real time RT-PCR technique [1], and quantified by
serial dilutions of a positive control based on synthetic RNA. The
relationship between viral load and RIDT result was then analysed.
Investigation of Virus Infection in a Summer Camp
The investigation protocol presented here was elaborated by the
French ‘‘Institut National de Veille Sanitaire’’ and validated by the
Ethic Committee ‘‘ CPP Ile-de-France IX’’.
InJuly 2009,a clusterof cases ina summer campinBarcelonnette
(Alpes-de-Haute-Provence, France) was investigated. Case definition
for analysis was as follows: possible cases were individuals with acute
respiratory syndrome (coughing or dyspnoea) + a general presenta-
tionofviralinfection(fever.38uC,orastheniaormyalgia);probable
cases were possible cases who had a close contact with a confirmed
case (in the period encompassing 2 days before and 7 days after the
onset of the first symptom of this confirmed case; confirmed cases
were possible or probable cases with microbiological confirmation
(positive RT-PCR from nasal swab).
All 94 children (6 to 14 years old, median: 10) had arrived in the
summer camp on July 20
th. They were supervised by 28 adults (16
counsellors or members of the management team and 12 technical
agents, i.e. kitchen and cleaning staff).
During the investigation process, one nasal swab could be
sampled from 95% of probable cases and 85% of ‘‘non-cases’’.
Samples were submitted to H1N1sw detection using the same RT-
PCR methods as reported above.
Prevalence of Antibodies to the New H1N1 Variant
This research protocol was approved by the Departmental
(IFR48) Ethic Committee and did not require patient consent.
Only biological archival material was used (no specific sampling,
no modification of sampling procedures). All information con-
tained in databases was de-identified.
Figure 1. Samples tested from April to August 2009. Panel A corresponds to Level A laboratory samples (N=99) tested between April 25
th
2009 and June 15
th 2009. Panel B corresponds to Level A laboratory samples (N=280) tested between April 25
th 2009 and July 13
th 2009. Panel C
corresponds to all samples (N=1,815) tested between April 25
th 2009 and August 31
st 2009, including Point of Care (POC) samples.
doi:10.1371/journal.pone.0009214.g001
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March 2009 (before the detection of the first cases of H1N1sw
infections on the French territory) in our laboratory for performing
a variety of serological investigations was established. Six hundred
sera distributed in 4 age groups (0–19, 20–39, 40–59 and .60)
were randomly selected in this collection, until an equal number of
150 sera in each age group was reached.
Antibodies to the new H1N1sw virus were detected and
quantified by the standard hemagglutination inhibition (HI)
technique. The antigen was prepared from cell culture supernatant
medium obtained following a seven-day propagation of strain
OPYFLU-1 at high m.o.i. onto MDCK cells. Serial dilutions of
heat-decomplemented serum (1/20–1/5,120), four viral hemag-
glutinating units and a suspension of human erythrocytes (group
O, final concentration: 0.5%) were used in a final volume of
50 mL. In addition, a subgroup of 300 randomly selected human
serum samples was tested using antigens from seasonal influenza
viruses, i.e. one strain of seasonal H1N1 (Marseille-2007), and one
strain of seasonal H3N2 (Marseille-2008).
Sequence Analysis
The complete sequence of the hemagglutinin (HA) and
neuraminidase (NA) genes of two different H1N1sw strains
were analysed. Strain OPYFLU-1 was isolated from nasal
swabs sampled from a young adult male patient returning from
Mexico in early May 2009, following inoculation onto MDCK
cells. Strain OPYFLU-58 was isolated from a case of
autochthonous viral transmission (teenager, male) in late July.
After RNA extraction from infected cell culture supernatant
medium using the EZ1 Biorobot and the virus mini kit (both
from Qiagen), one-step RT-PCR reactions were performed
using the Access RT-PCR Core Reagents Kit (Promega
Corporation, Madison, WI, USA) on TProfessional Standard
Thermocycler (Biometra biomedizinische Analytik GmbH
Goettingen Germany) and H1N1sw specific primers available
upon request to the corresponding author [17] (WHO Genome
Primers). PCR-fragments of 1,809 (HA gene) and 1,362
nucleotides (NA gene) were obtained and sequenced (Big Dye
Terminator v1.1 Cycle Sequencing kit, Applied Biosystems,
Foster City, CA,USA). Data from sequencing reactions were
combined for analysis and edited using the Sequencher 4.7
software (Gene Codes Corporation).
Sequences were analysed and compared with H1N1sw 2009
HA and NA sequences available in databases at mid-October
2009. Complete HA and NA amino-acid sequences were
aligned with ClustalX [18] and phylogenetic trees were built
using nucleotide or amino-acids alignments with MEGA
version 4.1 [19] using various methods (Neighbor-Joining,
Maximum Parsimony and UPGMA) with 1,000 bootstrap
replicates.
Table 1. Etiology of viral respiratory infections in Panel A.
Viral etiology Number Country Detection protocol
Influenza virus A virus H1N1sw 2009 15 UK (1), USA (4), Spain (1),
Canada (3), Mexico (2), France (4)
Ninove L, Vector Borne Zoonotic Dis. 2009
Influenza virus A virus H3N2 2 UK (1), USA (1) Van Elden L.J.R, J Clin Microbiol. 2001
Influenza virus B virus 0 / Van Elden L.J.R, J Clin Microbiol. 2001
Influenza virus C virus 0 / Gouarin S, J Med Virol. 2008
Rhinovirus 5* USA (1), France (3), Japan (1) Garbino J, Am J Respir Crit Care Med. 2004
Metapneumovirus 2* UK (1), France (1) Mackay IM, J Clin Microbiol. 2003
Respiratory Syncytial Virus A/B 0 / Van Elden L.J.R, J Clin Microbiol. 2003
Human Coronavirus 229E 1* Canada (1) Van Elden L.J.R, J Infect Dis 2004
Human Coronavirus OC43 2 USA (2) Van Elden L.J.R, J Infect Dis 2004
Human Coronavirus NL63 0* / Tiveljung-Lindell A, J Med Virol. 2009
Human Coronavirus KU1 0 / Tiveljung-Lindell A, J Med Virol. 2009
Enterovirus 1 France (1) Dierssen U, J Clin Virol. 2008
Parechovirus 0 / Benschop K, J Clin Virol 2008
Polyomavirus KI 0 / Lindau C, J Clin Virol. 2009
Polyomavirus WU 1* USA (1) Lindau C, J Clin Virol. 2009
Parainfluenza virus 1/2/3/4 5 USA (2), Mexico (2), Unknow (1) Tong S, J Clin Microbiol. 2008
Bocavirus 4 France (2), Australia (1), Unknow (1) Allander T, Clin Infect Dis. 2007
Cytomegalovirus 0 / Griscelli F, J Clin Microbiol. 2001
Human Coronavirus 229E + Polyomavirus WU 1 USA (1) /
Human Coronavirus NL63 + Rhinovirus 1 Mexico (1) /
Metapneumovirus + Polyomavirus WU 1 Mexico (1) /
Negative samples 58 UK (2), USA (15), Spain (3), Canada (4),
Mexico (14), France (15), Unknown (5)
/
Total number 99 / /
The etiological agent, the number of cases, the geographical origin of patients returning from abroad and the references for the methods used for molecular diagnosis
are indicated.
*: see also multiple infections.
doi:10.1371/journal.pone.0009214.t001
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First 99 Samples Collected from Suspected Cases in the
Southern Defence Zone (Panel A)
All 99 samples were collected from symptomatic patients
returning from abroad (Mexico (n=20), USA (n=27), Canada
(n=8), Japan (n=1), Australia (n=1), UK (n=5), Spain (n=4),
unknown (n=7), see table 1) or who had close contact with a
patient returning from abroad (26 patients). The median age
was 33 (range: 0–76 years) and the m/f sex ratio was 0.94. The
distribution in age groups (see figure 2A) demonstrates that the
majority of travellers were in the 20–60 years old age group with
a limited number of patients under 20 and above 60. Most of
t h ec h i l d r e nt e s t e dw e r el e s st h a n5y e a r so l d .
Results are detailed in table 1 and show that in 41% of cases,
one or several possible viral etiologic agents were identified. The
pandemic influenza virus was found in 15% of cases but
rhinoviruses, pneumoviruses, coronaviruses, enteroviruses, poly-
omaviruses, and parainfluenza viruses could also be identified. No
case of multiple infection implicating influenza and another agent
was detected. Among H1N1sw positive patients, the median age
was 32 and the sex ratio was 0.75.
The distribution of respiratory viral pathogens detected
in age groups is detailed in figure 2B. The percentage of etiological
identification (including the percentage of H1N1sw detection) was
similar in all age groups. Most of the cases of H1N1sw infection
(11 out of 15, i.e. 73%) were found in the 20–60 age group (which
included 70% of the samples studied), while 20% of cases were
identified in the group of patients less than 20 years old (which
included 18% of the samples studied).
Samples Collected for the Documentation of Suspected
Cases (Panels B and C).
Panel B included 280 samples collected between April 25
th,
2009 and July 13
th, 2009 using the systematic criteria for suspected
Figure 2. Etiology of viral respiratory infections in Panel A by age groups. Figure 2A shows the distribution in age groups of suspected cases tested/
positive for H1N1sw. Figure 2B details the different etiologies in each age group. *: includes 3 co-infections. EV: enteroviruses; WU: WU polyomavirus; PARAINF:
parainfluenza viruses 1/2/3/4; COR NL63: human coronavirus NL63; COR OC43: human coronavirus OC43; COR 229E: human coronavirus 229E; MPV: human
metapneumovirus; RH: rhinoviruses; BOCA: bocaviruses; H3N2: influenza A virus H3N2; H1H1: influenza A virus H1N1sw. Und: undetermined.
doi:10.1371/journal.pone.0009214.g002
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was 33 (range: 0–90 years), i.e. similar to that of panel A. The
distribution in age groups is reported in figure 3A for 270 patients
of known age and shows the lowest numbers under 10 years of age
(10%) and over 60 (10%), and also a first readjustment compared
with panel A: the number of samples tested in the 10–19 age group
increased (13%) and the highest rate of positive H1N1sw diagnosis
(above 30%) was observed in this group. Overall, 65% of H1N1sw
cases were identified in patients 10–39 years old, explaining the
decreased observed median age (25.5) amongst H1N1sw positive
patients. The sex ratio in H1N1sw patients was 0.96.
Panel C included all 1,815 nasal swabs tested between April 25
th
2009 and August 31
st 2009 in our laboratory, received either from
the general survey of the population within the Southern Defence
Zone or from patients hospitalised in the Public Hospitals of
Marseilles. The sex ratio was 1.03 and the median age was 24
(range: 0–98 years), i.e. lower than in panels A and B. The
distribution in age groups (see figure 3B which includes 1,779
Figure 3. Distribution of cases in age groups for Panel B and C. Figure 3A and 3B show the distribution of cases in age groups for the Panel B
and C respectively. The figure includes only patients whose age was known (270 patients from Panel B and 1799 in Panel C). The column on the left
shows the number of samples tested, positive for H1N1sw or positive for seasonal H3N2 virus in each age group. The column in the middle shows the
percentage of samples testing positive for H1N1sw in each age group. The column on the right shows the distribution of positives in the different
age groups.
doi:10.1371/journal.pone.0009214.g003
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for children under the age of 10 increased sharply (25%), and
remained limited for patients over 60 years old (10%). Again, the
highest rate of positive H1N1sw diagnosis was observed in the age
group 10–19 years old. Approximately 50% of all infections were
found in patients under the age of 20 (median age of H1N1sw
positive patients: 21; sex ratio: 1.07) and very few cases (less than
1%) were identified in patients over 60 years old. This distribution
is strikingly similar (see figure 4) to the picture of the distribution of
H1N1 seasonal influenza reported by [20] in various geographical
locations and periods of time, but also very different from the
distribution reported by the same authors for H3N2 viruses (which
included a significantly higher number of cases in the elderly).
Statistical analysis showed a different distribution of positives in
different age groups: the number of cases was significantly lower in
patients over 40 years old (Panel B, p=0.005; Panel C, p,0.0001)
compared with younger patients.
Figure 5 shows the evolution of the situation over time in Panel
C. Interestingly, the proportion of influenza infections caused by
seasonal H3N2 constantly decreased during the period of the study
(final value ,5%), but the absolute number of cases observed
weekly remained roughly constant, suggesting that seasonal
influenza circulated at low rate during this summer period (a
phenomenon never observed previously and which may reflect the
previous poor performance of the routine surveillance systems
implemented for respiratory infections) and that this circulation
was not markedly modified by the increasing number of cases of
H1N1sw infections.
Viral Loads, Results of RIDTs
Analysis of the results of RIDT for the detection of influenza A
and B antigens showed that no false positive was identified
(Specificity and Positive Predictive Value =100%), but false
negative results were encountered. Accordingly, the relationship
between age, viral load and result of RIDTs was investigated. First,
amongst 233 samples positive for H1N1sw based on RT-PCR
techniques, the distribution of positive RIDTs in age groups was
examined (see figure 6A). This revealed an optimal sensitivity
(,75%) in patients younger than 15 (p,0.001, compared with
other age groups) and a poor sensitivity in patients over 45
(,25%).
The relationship between viral load and RIDT result was then
analysed (see figure 6B). This revealed that samples with high viral
loads (.10 million copies/mL) could be constantly detected by the
BD RIDT. The sensitivity of the RIDT test decreased with viral
load and no positive result was obtained for samples with viral
loads ,0.11 million copies/mL. The relationship between viral
load and results of RIDT was supported by statistical tests.
Overall the strong relationship between positive RIDTs and
high viral loads on the one hand, and the group of patients in the
age group 0–15 on the other hand, strongly suggests that viral
excretion is more pronounced in children, in accordance with
previous results obtained for seasonal influenza [21,22].
Investigation of Virus Infection in a Summer Camp
45 persons met the definition of probable or confirmed cases.
They all reported coughing and 82% reported fever .38uC (see
table 2). Thirty six cases were children (median age: 11; extremes:
8–13) and 9 were adults (median age: 22; extremes: 19–50). There
Figure 4. Empirical cumulative distribution of ages for patients
with seasonal H1N1 or novel H1N1sw virus. We show the
empirical cumulative distribution of ages for patients with seasonal
H1N1 (blue) in New York State during the 2006–2007 and 2007–2008
influenza seasons and for H1N1sw (red) in Panel C.
doi:10.1371/journal.pone.0009214.g004
Figure 5. Weekly distribution of samples tested and samples positive for H1N1sw or seasonal H3N2 virus.
doi:10.1371/journal.pone.0009214.g005
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and non-ill children. The chronological onset of cases is
represented in the epidemic curve (see figure 7). Children and
counsellors had been distributed in different groups (A, B, C, D,
E). All individuals in a given group were sharing daytime activities
and were sleeping at night on the same floor in the main building
of the camp, with the exception of few children from group C,
including the index case, who shared the floor of teenagers of
group D. The index case was retrospectively identified and
occurred on the day of arrival of the children in the camp. No
history of travel or previous contact with a suspected case could be
identified for this child. The outbreak peak was reached eight days
after the onset of the index case. An alert was then issued, and a
case-management procedure was implemented, with physical
separation between symptomatic and asymptomatic children
(and adults). The investigation was performed 2 days after the
alert in a period characterized by the rapid decline of the
outbreak.
The global attack rate was 38% in children, 37.5% in adults
managing children, and 25% in technical agents. It was therefore
similar in children and adults in close contact with them. However,
this attack rate was different in the different groups varying from
19% in group A to 57.5% in group D. The latter group was
constituted by teenagers (10–14 years old) which represented the
majority of the secondary cases observed during the first days of
the outbreak (see figure 7).
During the investigation process, one nasal swab could be
sampled from 95% of probable cases and 85% of ‘‘non-cases’’.
Samples were submitted to H1N1sw detection using the same
RT-PCR methods as reported above. Interestingly, the virus
was detected in 7 of the 67 ‘‘non-cases’’ tested (10,4%). One
was a child with fever and asthenia but without any respiratory
symptoms. A telephone follow-up of the 6 remaining
asymptomatic persons was organised. One child and one
counsellor experienced coughing and fever by July 31
st and
were included in data analysis (see figure 7). One week after
sampling, two children had experienced isolated rhinitis, but
two others remained totally asymptomatic. Finally, amongst
the 7 ‘‘non-cases’’ tested, 2 became typical influenza cases,
3 had atypical presentations, and 2 remained completely
asymptomatic.
Figure 6. Results of RIDTs according to age groups and viral
load. Figure 6A shows the distribution of positive RIDTs in age groups
amongst 233 samples positive for H1N1sw based on RT-PCR
techniques. Figure 6B shows the distribution of positive RIDTs
according to viral load amongst 41 samples. *: p,0.001 (chi-square
test); compared with all other samples.
doi:10.1371/journal.pone.0009214.g006
Table 2. Clinical symptoms observed in 45 probable and
confirmed cases in a summer camp, July 2009.
Symptoms N %
Coughing 45 100
Fever 37 82
Asthenia 34 76
Headache 27 60
Myalgia 27 60
Sore throat 27 60
Shivering 17 38
Rhinitis 15 33
Nausea 6 13
Dyspnoea 5 11
doi:10.1371/journal.pone.0009214.t002
Figure 7. Probable and confirmed cases in a summer camp,
July 2009. White cubes figure children; pink cubes figure counsellors/
management team; yellow cubes figure technical staff. Letters indicate
the group (see main text) and the cubes with a black corner indicate
microbiological confirmation.
doi:10.1371/journal.pone.0009214.g007
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The prevalence of antibodies to the new H1N1sw variant in
patients under and above the age of 40 is shown in figure 8. The
prevalence at different titres ($1/40, $1/80, $1/160) is
significantly lower in patients under the age of 40 (p,0. 0001).
This distribution is different from that observed for antibodies to
H1N1 and H3N2 seasonal viruses. In the case of seasonal H1N1,
the prevalence of HI titre $1/40 is similar to that observed for
H1N1sw amongst patients under the age of 40, but slightly lower
in patients over 40. However, no statistical relationship could be
identified between individual titres of antibodies to H1N1sw and
seasonal H1N1. For seasonal H3N2, the prevalence of HI titre
$40 is higher in both groups (with an important difference for
patients under the age of 40). Again, no statistical relationship
could be identified between individual titres of antibodies to
H1N1sw and seasonal H3N2.
Figure 9 shows a more detailed distribution of antibodies to
H1N1sw in age groups. A similar age-dependent fluctuation of
prevalence was observed for all HI titres, but it should be noted
that the prevalence of titres $1/160 remains globally modest at all
ages.
Sequence Analysis
Comparative analysis of genetic amino acid distances amongst
H1N1sw 2009 HA and NA sequences available in databases at
mid-October 2009 revealed that the genetic diversity of protein
sequences was minor, but slightly more notable in the NA gene
(,2% vs ,1% in HA gene). OPYFLU-1 and OPYFLU-58 HA
protein sequences were identical (with 3 synonymous substitutions)
but 2 non-synonymous differences were detected in the NA gene
(V106I, N248D) in addition to 3 non-synonymous mutations.
There was no evidence of resistance to neuraminidase inhibitors in
either strain. Interestingly, strains appeared to segregate according
to the nature of residues 106 and 248. When using amino acid
sequences, various methods used for tree building (including
distance-based neighbor joining and maximum parsimony recon-
structions) provided a similar topology, with VN strains appearing
ancestral, separate clusters including VD and IN sequences and
finally a large group of ID sequence that seemed to have emerged
more recently from a common ancestor (see figure 10A). This
chronology is globally validated by the analysis of dates at which
the corresponding strains were collected (see figure 10B). Howev-
er, bootstrap resampling values at forks delineating the main
clusters are low (,50), a possible consequence of the limited
genetic distances between the different strains studied. Analysis
performed using nucleotide sequences similarly provided phylo-
genetic inconclusive results with similar grouping of strains
according to their VN, VD, IN or ID pattern.
Discussion
In a number of countries, the appearance of the H1N1sw
pandemic resulted in reinforcement of the surveillance of
influenza-like illnesses (ILIs). In countries located in the Northern
hemisphere, this led to a follow up of ILIs during the spring and
summer periods. Paradoxically, this revealed our limited knowl-
edge concerning the epidemiology of viral respiratory diseases
outside the winter epidemic season and contributed novel
information regarding the new H1N1sw variant, but also seasonal
influenza viruses, and other viral respiratory pathogens.
The study of the first 99 suspected cases identified in the French
Southern Defence Zone showed that this population (mainly
constituting adults 20–60 years old returning from abroad) was
infected by a variety of respiratory viruses such as rhinoviruses,
pneumoviruses, coronaviruses, enteroviruses, polyomaviruses, and
parainfluenza viruses. Our analysis of this limited sample did not
identify associations between age and specific pathogens. It
provided results in agreement with those previously published by
Follin and collaborators [23] and confirmed the difficult etiological
identification of ILIs based on clinical presentation. One
interesting aspect of this study was the identification of ‘‘seasonal’’
H3N2 influenza virus in June, July and August, which co-
circulated at a low rate with the pandemic H1N1sw virus. This
may appear to be an unusual feature in Southern France during
summertime, but strongly suggests that such cases occur regularly
and are just not detected by our standard surveillance system
which focuses on investigations during the winter season.
Therefore, the characteristics of the circulation of the influenza
A virus may be much more complex than previously believed and
our results suggest that the complete picture may include the
circulation of ‘‘seasonal’’ virus during the April-August period in
Figure 8. Prevalence of antibodies to H1N1sw and seasonal
influenza viruses according to age. The prevalence of antibodies to
H1N1sw is given for HI titres $1/40, $1/80 and $1/160. The prevalence
of antibody to seasonal H1N1 (using a strain isolated in Marseille in
2007), and to seasonal H3N2 (using a strain isolated in Marseille in 2008)
is given for HI titres $1/40.
doi:10.1371/journal.pone.0009214.g008
Figure 9. Prevalence of antibody to H1N1sw according to age
groups. The prevalence is given for HI titres $1/40, $1/80 and $1/
160.
doi:10.1371/journal.pone.0009214.g009
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9214Figure 10. Phylogenetic and temporal distribution of H1N1sw isolates. Figure 10A shows the phylogenetic distribution of H1N1sw
isolates based on complete amino acid neuraminidase sequences. The label of each strain includes the GenBank number, the country of origin,
the time of collection and the amino acid pattern at residue positions 106 and 248 of the neuraminidase protein. Figure 10B shows the temporal
distribution of strains harbouring the VN or ID amino acid pattern at residue positions 106 and 248 of the neuraminidase protein. Figure 10B:
Green circle: strains with VN pattern. Pink triangle: strains with ID pattern. Dark blue square: strains with VD pattern. Light blue square: strains
with IN pattern.
doi:10.1371/journal.pone.0009214.g010
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hemisphere: in our series, patients with H3N2 infections returned
from Australia, but also from the UK or the USA.
Regarding H1N1sw infection, it was identified originally in
travellers returning from abroad (75% in Panel A, including a
majority of adults) or in patients in close contact with them (25%).
This pattern was progressively modified and, notably, the number
of patients who did not travel and could not identify any link with
suspected cases, as well as the number of patients under the age of
10 tested for H1N1sw infection, increased progressively. The final
picture (see figures 3B and 4) is very similar to the epidemiological
distribution of H1N1 seasonal virus usually observed in age
groups, with ,50% of cases under the age of 20, a decreasing
number of cases in age groups over the age of 20 and, notably, a
very limited number of cases in patients over 60 years old.
Superimposing the curves of empirical cumulative distribution of
ages for patients with seasonal H1N1 in New York State during
the 2006–2007 and 2007–2008 influenza seasons, and for
H1N1sw in Panel C shows a striking similarity. Only one
difference is observed in the 2–12 years old age group, in which
the number of cases is slightly lower in our series. However, it must
be noted that, in the current study, the investigation of clusters of
cases (implicating a majority of children under the age of 15) was
limited to sampling a few individuals per cluster. Therefore, the
actual number of cases in children was underestimated and is most
probably similar to that reported for seasonal H1N1 by [20] (in the
latter study, 47% of the detected H1N1 cases were reported in
patients younger than 20 years). The most remarkable difference
observed by [20] between seasonal H1N1 (and thus H1N1sw) and
H3N2 distribution, is the number of cases occurring in the elderly,
(H1N1 does preferentially target a younger population). One
reason that may underlie this difference is the weaker antigenic
drift in H1N1, associated with co-circulation of multiple H1N1
lineages and weaker H1N1 bottleneck effects between seasons
compared to those of H3N2 [20,24]. Indeed, in the current series
the number of cases detected in patients over 60 years old is
remarkably low: less than 1% in both Panels B and C whilst this
age group provided 10.5% of the patients tested in these two
panels.
This distribution of cases in age groups is of special interest in
the light of HI serological results (see figures 8 and 9): regardless of
the antibody titre considered, it appears clear that the prevalence
of antibodies to H1N1sw is low under the age of 30. Since it is
extremely improbable that strains related to H1N1sw circulated in
human populations during the last 20 or 30 years, the value
observed for young patients is likely to be due to cross reactivity
with seasonal influenza and thus indicative of the global
overestimation of the prevalence provided by the HI assay
(according to this hypothesis, around 10%). In individuals over
40, the prevalence is clearly disconnected from that observed for
seasonal viruses and suggests previous exposure (presumably
before 1970) to influenza virus(es) antigenically related to the
current H1N1sw. However, much earlier circulation (i.e. before
1940 and possibly between the first and the Second World War) of
H1N1sw-related strains cannot be ruled out considering the high
prevalence values observed for patients over 80.
This suggests a ‘‘cause and effect’’ relationship, i.e. protection
provided by specific antibodies. However, this interpretation
should be considered tenuous since the significance of the titres of
HI antibodies detected, in terms of protection against infection/
asymptomatic infection/severe forms, is unknown. Moreover, if
the group of elderly individuals appears to be collectively prone to
a low incidence of H1N1 and H1N1sw infections (at least of
symptomatic infections), individuals without immunity to the virus
do exist in this age group. Their precise number is unknown since
the antibody level (HI titre) that may provide effective protection is
undetermined, but the occurrence of a low incidence in this age
group does not eliminate during the outbreak the risk of
complicated forms and high mortality as classically observed in
the case of seasonal influenza infection.
Concerning diagnosis of the acute infection, it is generally
considered that the only reliable tool was the detection of viral
genomes using molecular biological methods. Our comparative
analysis of results obtained in parallel that incorporated molecular
biology and a RIDT led to a more subtle assessment. We found
that the positive predictive and specificity values of the RIDTs
used were 100% and that the sensitivity in the age group 0–15 was
75%. Comparative analyses with studies investigating the
performance of RIDTs suggest that the RIDT used in the current
study performs better than others. This deserves further
investigation. However, it also suggests that RIDT may be useful
for rapid investigation of clusters of paediatric cases, and that they
may also be particularly useful at the peak of the outbreak: we
could calculate that (in the case of children under the age of 15 and
under the hypothesis of a ratio of 2 between the price of the
molecular test and that of the RIDT) the cost of a strategy
associating a systematic RIDT and a molecular test for all
negatives would become more attractive than systematically
testing all samples by molecular biology for prevalence of influenza
infection over 60%.
Another conclusion that could be drawn from the use of RIDTs
is, in the case of H1N1sw, the more important viral excretion in
children under the age of 15 compared with other age groups (see
figure 6A). Actually, children were associated with the highest
sensitivity of the test and, simultaneously, positive results of RIDTs
could be associated with elevated viral loads (see figure 6B). This
confirms previous results showing that the highest attack rates of
seasonal influenza observed in communities of schoolchildren are
accounted for by the shedding of higher titres of virus for a longer
period than other patient groups [21,22]. In the specific case of
H1N1sw, similar results were observed suggesting that clinical
attack rates in children under 15 years of age in La Gloria were
twice those observed in adults [25].
The investigation of a cluster of cases in a summer camp showed
the rapid spread of the virus in individuals living in the immediate
vicinity of the index case. Interestingly, the attack rate observed in
children (median age 11) was similar to that observed in young
adults supervising them (median age 22). This strongly suggests
that the shedding of higher titres of virus by children is the major
parameter associated with high attack rates. However, it was also
noticed that attack rates in children increased with age sub-groups,
the risk of infection among teenagers being 3 times the risk of the
youngest (under 8 years old). This difference may be, in the case of
the current investigation, explained in part by the physical
separation of children in different groups, but may also reflect
specific behaviour or susceptibility to infection in different age
groups.
Finally, the genetic characterisation of a strain isolated in the
early period (May) of the outbreak from a patient returning from
Mexico, and that of a strain isolated in July 2009 from a French
autochthonous case revealed two mutations at positions 106 and
248 of the neuraminidase protein. Residue 106 is located at the N
terminus of the neuraminidase domain and closely related to the
trans-membrane domain. Residue 248 is located at the surface of
the protein and part of an antibody recognition site [26]. It may
therefore be associated with antigenic shift. The N248D mutation
has previously been reported in H1N1 human strains isolated in
the thirties, forties, seventies, eighties and nineties. Sequence
Novel H1N1 Virus in SE France
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106-
N
248 pattern at the origin of the outbreak. After May 2009, the
decline of V
106-N
248 strains was concomitant with the emergence
of I
106-D
248 strains. The mechanism of emergence of ID strains
remains unclear: such strains may have emerged from a common
ancestor and disseminated secondarily, but this hypothesis is
epidemiologically puzzling and poorly supported by phylogenetic
analyses in other genes such as HA. The alternative hypothesis (a
common selection process may have lead to convergent evolution
towards ID strains originating from various VN ancestors) cannot
be ruled out and would suggest that evolutionary constraints led to
the decline of V106-N248 strains after May 2009 and the
emergence of I106-D248. To our knowledge, this phenomenon
has not been associated to date with a change in the epidemiology
or clinical presentation of the viral infection, but certainly deserves
a careful follow up during the coming months.
Author Contributions
Conceived and designed the experiments: DR RNC XdL. Performed the
experiments: AN LN CZ CG. Analyzed the data: AN LN CZ KM NR
RNC XdL. Contributed reagents/materials/analysis tools: AN LN NS
KM NR CG. Wrote the paper: AN LN XdL.
References
1. Levy-Bruhl D, Vaux S (2009) Modified surveillance of influenza A(H1N1)v virus
infections in France. Euro Surveill 14.
2. Nougairede A, Ninove L, Zandotti C, De Lamballerie X, Gazin C, et al. (2009)
Point of Care strategy for rapid diagnosis of novel A/H1N1 influenza virus.
PLoS Currents Influenza RRN1039.
3. Ninove L, Gazin C, Gould EA, Nougairede A, Flahault A, et al. (2009) A Simple
Method for Molecular Detection of Swine-Origin and Human-Origin Influenza
A Virus. Vector Borne Zoonotic Dis.
4. Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, et al. (2007) Human
bocavirus and acute wheezing in children. Clin Infect Dis 44: 904–910.
5. Benschop K, Molenkamp R, van der Ham A, Wolthers K, Beld M (2008) Rapid
detection of human parechoviruses in clinical samples by real-time PCR. J Clin
Virol 41: 69–74.
6. Dierssen U, Rehren F, Henke-Gendo C, Harste G, Heim A (2008) Rapid
routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-
time RT-PCR assay. J Clin Virol 42: 58–64.
7. Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, et al. (2004)
Lower respiratory viral illnesses: improved diagnosis by molecular methods and
clinical impact. Am J Respir Crit Care Med 170: 1197–1203.
8. Gouarin S, Vabret A, Dina J, Petitjean J, Brouard J, et al. (2008) Study of
influenza C virus infection in France. J Med Virol 80: 1441–1446.
9. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, et al. (2001)
Quantification of human cytomegalovirus DNA in bone marrow transplant
recipients by real-time PCR. J Clin Microbiol 39: 4362–4369.
10. Lindau C, Tiveljung-Lindell A, Goh S, Ramqvist T, Allander T (2009) A single-
tube, real-time PCR assay for detection of the two newly characterized human
KI and WU polyomaviruses. J Clin Virol 44: 24–26.
11. Mackay IM, Jacob KC, Woolhouse D, Waller K, Syrmis MW, et al. (2003)
Molecular assays for detection of human metapneumovirus. J Clin Microbiol 41:
100–105.
12. Tiveljung-Lindell A, Rotzen-Ostlund M, Gupta S, Ullstrand R, Grillner L, et al.
(2009) Development and implementation of a molecular diagnostic platform for
daily rapid detection of 15 respiratory viruses. J Med Virol 81: 167–175.
13. Tong S, Chern SW, Li Y, Pallansch MA, Anderson LJ (2008) Sensitive and
broadly reactive reverse transcription-PCR assays to detect novel paramyxovi-
ruses. J Clin Microbiol 46: 2652–2658.
14. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM (2001)
Simultaneous detection of influenza viruses A and B using real-time quantitative
PCR. J Clin Microbiol 39: 196–200.
15. van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI,
et al. (2004) Frequent detection of human coronaviruses in clinical specimens
from patients with respiratory tract infection by use of a novel real-time reverse-
transcriptase polymerase chain reaction. J Infect Dis 189: 652–657.
16. van Elden LJ, van Loon AM, van der Beek A, Hendriksen KA, Hoepelman AI,
et al. (2003) Applicability of a real-time quantitative PCR assay for diagnosis of
respiratory syncytial virus infection in immunocompromised adults. J Clin
Microbiol 41: 4378–4381.
17. World-Health-Organization (2009) Sequencing primers and protocol (Pandemic
(H1N1) 2009 guidance documents). http://wwwwhoint.
18. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The
CLUSTAL_X windows interface: flexible strategies for multiple sequence
alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876–4882.
19. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
20. Khiabanian H, Farrell GM, St George K, Rabadan R (2009) Differences in
patient age distribution between influenza A subtypes. PLoS One 4: e6832.
21. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, et al. (1981) Patterns of
shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 144:
433–441.
22. Munoz FM (2002) The impact of influenza in children. Semin Pediatr Infect Dis
13: 72–78.
23. Follin P, Lindqvist A, Nystrom K, Lindh M (2009) A variety of respiratory
viruses found in symptomatic travellers returning from countries with ongoing
spread of the new influenza A(H1N1)v virus strain. Euro Surveill 14.
24. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008)
The genomic and epidemiological dynamics of human influenza A virus. Nature
453: 615–619.
25. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al.
(2009) Pandemic potential of a strain of influenza A (H1N1): early findings.
Science 324: 1557–1561.
26. Maurer-Stroh S, Ma J, Lee RT, Sirota FL, Eisenhaber F (2009) Mapping the
sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative
to drug and antibody binding sites. Biol Direct 4: 18; discussion 18.
Novel H1N1 Virus in SE France
PLoS ONE | www.plosone.org 11 February 2010 | Volume 5 | Issue 2 | e9214